1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,000 | 20.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.03. | Tevogen Bio Inc: Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization | 269 | GlobeNewswire (Europe) | Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next... ► Artikel lesen | |
| 13.03. | Tevogen Bio Inc: Tevogen.AI Reports Advancements in PredicTcell Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure | 336 | GlobeNewswire (Europe) | WARREN, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced performance advancements for its artificial intelligence platform... ► Artikel lesen | |
| 11.03. | Tevogen Bio Inc: Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform | 2 | GlobeNewswire (USA) | ||
| 09.03. | Tevogen Bio Inc: Tevogen Names Leadership Team to Execute Diversified Growth Strategy | 342 | GlobeNewswire (Europe) | WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced the appointment of interim leaders across its core business verticals... ► Artikel lesen | |
| 06.03. | Tevogen Bio Inc: Letter to Shareholders from CEO Dr. Ryan Saadi | 623 | GlobeNewswire (Europe) | WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN). Dear Shareholders, As we continue executing on Tevogen's long-term strategy to evolve... ► Artikel lesen | |
| TEVOGEN BIO Aktie jetzt für 0€ handeln | |||||
| 06.03. | Tevogen Bio Explores Buyout To Boost Generics Platform | 6 | Benzinga.com | ||
| 06.03. | XFRA G280: AUSSETZUNG/SUSPENSION | 213 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILTEVOGEN BIO HLDGS... ► Artikel lesen | |
| 06.03. | XFRA NEW INSTRUMENTS AVAILABLE ON 06.03.2026 | 271 | Xetra Newsboard | The following instruments on XETRA do have their first trading 06.03.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 06.03.2026
Aktien
1 CA3027351053 Fab-Form Industries... ► Artikel lesen | |
| 05.03. | Tevogen Bio Inc: Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical | 194 | GlobeNewswire (Europe) | WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter... ► Artikel lesen | |
| 05.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.03.2026 | 487 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.03.2026.ISIN NameCA37640A4028 GLACIER... ► Artikel lesen | |
| 05.03. | XFRA ISIN CHANGE | 300 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA37640A4028 Glacier Lake Resources Inc. 05.03.2026 CA83058E1060 Glacier Lake Resources Inc. 06.03.2026 Tausch 2,4:1US88165K1016 Tevogen... ► Artikel lesen | |
| 04.03. | Tevogen approves 1-for-50 reverse share split | 3 | Seeking Alpha | ||
| 04.03. | Tevogen Bio Inc: Tevogen Announces Reverse Stock Split | 173 | GlobeNewswire (Europe) | WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that its Board of Directors (the "Board") has approved a reverse... ► Artikel lesen | |
| 03.03. | D. Boral Capital senkt Kursziel für Tevogen Bio wegen Verwässerungsrisiko auf 2 $ | 5 | Investing.com Deutsch | ||
| 03.03. | D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk | 3 | Investing.com | ||
| 27.02. | Tevogen Bio Inc: Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization | 755 | GlobeNewswire (Europe) | WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter... ► Artikel lesen | |
| 26.02. | Tevogen Bio Inc: Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus | 592 | GlobeNewswire (Europe) | WARREN, N.J. and ROYAL OAK, Mich., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc.") (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding... ► Artikel lesen | |
| 25.02. | Tevogen Bio Holdings Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.01. | Tevogen Bio Holdings Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.01. | Tevogen board to evaluate potential special cash dividend | 1 | Investing.com |
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 34,805 | -1,28 % | Qiagen unter Druck, Zalando auf Erholungskurs: DAX-Ausblick | Der DAX befindet sich weiter auf Talfahrt. In der abgelaufenen Woche büßte das größte deutsche Börsenbarometer rund 144 Punkte ein und schloss -0,61% niedriger mit 23.447 Punkten. Die höchsten Verluste... ► Artikel lesen | |
| AMGEN | 298,60 | -0,85 % | Defensive Biotech-Wetten? Warum Amgen und AbbVie strukturell wachsen - kleiner Player Mesoblast im Fokus | ||
| NOVAVAX | 8,315 | -0,50 % | FOMO an der Wall Street: Novavax meldet überraschenden Gewinn - Aktie schießt zweistellig hoch | © Foto: picture alliance / Ulrich Baumgarten | Ulrich BaumgartenEin Ergebnis, das niemand erwartet hatte, gepaart mit neuen Big-Pharma-Deals: Novavax sorgt für FOMO an der Wall Street. Wie lange hält... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 22,550 | +7,38 % | Morning Market Movers: Super Micro Computer, Bimergen Energy, Palatin Technologies, Intellicheck See Big Swings | HONG KONG (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 632,00 | -0,32 % | EQS-News: Formycon AG: Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit Regeneron und Bayer | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,400 | 0,00 % | H.C. Wainwright reiterates Inovio stock rating on FDA review | ||
| COSCIENS BIOPHARMA | 0,795 | -19,70 % | COSCIENS Biopharma Inc.: COSCIENS Provides Strategic Update | TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company") today announced that the Company has made a strategic decision... ► Artikel lesen | |
| BIOMARIN PHARMACEUTICAL | 46,690 | -0,17 % | BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO | ||
| ARROWHEAD PHARMACEUTICALS | 47,850 | -1,77 % | ARROWHEAD PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| XOMA ROYALTY | 24,400 | +0,83 % | XOMA Royalty Corporation: XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements | Portfolio receipts: • Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 1,220 | +3,39 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office | Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector... ► Artikel lesen | |
| MOSAIC IMMUNOENGINEERING | - | - | Mosaic ImmunoEngineering Inc. - 10-Q, Quarterly Report | ||
| ORAGENICS | 0,690 | -7,99 % | ORAGENICS INC - 10-K, Annual Report | ||
| INSMED | 121,00 | +2,54 % | Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration | ||
| SWEDISH ORPHAN BIOVITRUM | 32,660 | -1,21 % | Swedish Orphan Biovitrum AB: Results from EMBRACE Phase 2a study of emapalumab in interferon-gamma-driven sepsis presented at ISICEM | Primary endpoint: improvement in organ function observed in 60% of patients receiving high-dose emapalumab vs 40% with standard of care plus placebo28-day mortality: 40% in the high-dose... ► Artikel lesen |
TEVOGEN BIO HOLDINGS INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,190 (-3,61 %) liegt der Kurs bei 5,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TEVOGEN BIO HOLDINGS INC finden Sie auf Wallstreet Online.